Alexandria Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$6.96M Buy
11,505
+471
+4% +$285K 0.64% 55
2021
Q2
$6.16M Buy
11,034
+5,514
+100% +$3.08M 0.57% 65
2021
Q1
$2.61M Buy
5,520
+797
+17% +$377K 0.26% 104
2020
Q4
$2.28M Sell
4,723
-3,369
-42% -$1.63M 0.24% 108
2020
Q3
$4.53M Buy
8,092
+2,168
+37% +$1.21M 0.54% 65
2020
Q2
$3.7M Buy
5,924
+3,874
+189% +$2.42M 0.48% 70
2020
Q1
$1M Buy
2,050
+291
+17% +$142K 0.16% 123
2019
Q4
$660K Buy
+1,759
New +$660K 0.09% 153
2017
Q4
Sell
-6
Closed -$3K 450
2017
Q3
$3K Sell
6
-6
-50% -$3K ﹤0.01% 486
2017
Q2
$6K Buy
12
+2
+20% +$1K ﹤0.01% 471
2017
Q1
$4K Sell
10
-409
-98% -$164K ﹤0.01% 506
2016
Q4
$154K Sell
419
-3,350
-89% -$1.23M 0.04% 150
2016
Q3
$1.52M Sell
3,769
-1,097
-23% -$441K 0.28% 70
2016
Q2
$1.7M Sell
4,866
-3
-0.1% -$1.05K 0.3% 75
2016
Q1
$1.76M Buy
4,869
+2,973
+157% +$1.07M 0.32% 70
2015
Q4
$1.03M Hold
1,896
0.26% 78
2015
Q3
$882K Sell
1,896
-1
-0.1% -$465 0.21% 83
2015
Q2
$1.03M Buy
1,897
+1,875
+8,523% +$1.02M 0.23% 78
2015
Q1
$10K Sell
22
-1
-4% -$455 ﹤0.01% 399
2014
Q4
$9K Sell
23
-2
-8% -$783 ﹤0.01% 382
2014
Q3
$9K Buy
25
+2
+9% +$720 ﹤0.01% 360
2014
Q2
$6K Buy
23
+5
+28% +$1.3K ﹤0.01% 428
2014
Q1
$5K Buy
18
+2
+13% +$556 ﹤0.01% 456
2013
Q4
$4K Buy
16
+2
+14% +$500 ﹤0.01% 493
2013
Q3
$4K Hold
14
﹤0.01% 494
2013
Q2
$3K Buy
+14
New +$3K ﹤0.01% 584